39 peer-reviewed studies · Evidence score: 7/10
Kocatürk RR et al. • The International journal of neuroscience (2023)
Better designed trials with holistic measures are needed to investigate the effect of nutritional support on the AD biomarkers, cognitive status, biochemical parameters and functional states.
Bentharavithana J et al. • International journal of molecular sciences (2025)
Further research is needed to elucidate the molecular mechanisms and confirm the safety and efficacy of medicinal mushrooms as a holistic anti-colon cancer treatment.
Gong P et al. • Molecular nutrition & food research (2025)
Future research should address these gaps, emphasizing personalized interventions and advanced technologies for next-generation antidepressant foods.
Taib NAB et al. • Medical sciences (Basel, Switzerland) (2026)
Conclusions: Despite presenting the potential use of mushrooms in managing PNIs, the existing approaches need to be subjected to clinical research to accelerate the development of future therapeutics and preventive measures for PNIs.
Contato AG et al. • Nutrients (2025)
The potential of H. erinaceus as a functional food, nutraceutical, and adjunct therapeutic agent highlights the need for interdisciplinary collaboration between researchers, clinicians, and regulatory bodies.
Cha S et al. • Neuroscience and biobehavioral reviews (2024)
Studies mainly investigated Lion's Mane (Hericium erinaceus), showing some enhancement of mood and cognitive function in middle-aged and older adults.
Alsoufi MH et al. • Brazilian journal of biology = Revista brasleira de biologia (2025)
In this study, we compiled a comprehensive inventory of bioactive compounds and examined their therapeutic capabilities, specifically focusing on their potential for exhibiting antiproliferative and neuroprotective pharmacological effects.
Ge F et al. • Molecules (Basel, Switzerland) (2025)
Additionally, it discusses the opportunities and challenges associated with scientific research and practical applications in this field.
Cornford N et al. • Nutrition research reviews (2025)
In conclusion, evidence suggests that intake of HE may be an appropriate and relevant future therapeutic treatment for the prevention and delayed progression of Alzheimer's disease; however, continued research is necessary to provide further significant evidence of this relationship, through an increased quantity of human clinical trials.
Łysakowska P et al. • Molecules (Basel, Switzerland) (2023)
This review focuses on the properties of selected medicinal mushrooms and their effects on the human organism and presents current knowledge on the possibilities of their use in the production of functional foods.
Shevchuk Y et al. • Ageing research reviews (2023)
Maitake or hen-of-the-woods), the genus Pleurotus (e.g. oyster mushrooms), and Agaricus subrufescens (i.e. the almond mushroom).
Hersant H et al. • CNS drugs (2023)
The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Gravina AG et al. • World journal of gastroenterology (2023)
In addition, some components of this mushroom appear to possess strong antineoplastic capabilities against gastric and colorectal cancer.
Gregory J et al. • Biomolecules (2021)
It is hoped that these medicinal plants can be used in drug discovery programs for identifying safe and efficacious small molecules for AD.
Yanshree et al. • Cells (2022)
In conclusion, Hericium erinaceus has therapeutic potential and may facilitate memory enhancement in patients with AD.
Kawagishi H • Bioscience, biotechnology, and biochemistry (2021)
We discovered antidementia compounds, hericenones C to H, from the fruiting bodies and erinacine A to I from the cultured mycelia of the fungus.
Winder M et al. • Acta pharmaceutica (Zagreb, Croatia) (2021)
The use of these extracts is justified stronger than the other supportive treat ments based on supplements.
Rai SN et al. • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2021)
In silico approaches provide an alternative method with low cost that has been successfully implemented to cure ND disorders in recent days.
Hetland G et al. • Nutrients (2020)
This article reviews preclinical and clinical findings with these mushrooms and the mechanisms behind them.
Chong PS et al. • International journal of molecular sciences (2019)
This article critically reviews the current literature on the potential benefits of H. erinaceus as a treatment for depressive disorder as well as its mechanisms underlying the antidepressant-like activities.